Overview

Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source

Status:
Completed

Trial end date:
2019-09-21

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether stem cells collected from a donor's blood stream will be as safe and effective as using bone marrow collected from a donor's pelvic bone.

Phase:

Phase 1

Details

Lead Sponsor:

Rafic Farah, MD
University of Pittsburgh

Treatments:

Cyclophosphamide
Fludarabine
Fludarabine phosphate
Mesna
Mycophenolate mofetil
Mycophenolic Acid
Sargramostim
Tacrolimus
Vidarabine